BURJEEL HOLDINGS PLC

Logotype for BURJEEL HOLDINGS PLC
Ticker/ISIN
BURJEEL
AEE01119B224
Market/Country
Abu Dhabi Stock Exchange
United Arab Emirates

About BURJEEL HOLDINGS PLC

The Group is one of the leading regional private healthcare service providers in the UAE and Oman, operating as an integrated network across primary, secondary, tertiary and quaternary medical care services. The Group provides a comprehensive healthcare ecosystem to patients across the full socio-economic spectrum through its four key market leading brands, Burjeel, Medeor, LLH and Lifecare, and its fully-funded network of 16 hospitals, 23 medical centres (including polyclinics and specialty medical centres with dental, cosmetic, homecare services, a specialised orthopaedics centre and IVF centres) and 15 pharmacies, as well as seven entities conducting allied services such as central procurement (e.g., GPO), revenue cycle management, centralised diagnostics, central warehousing and patient valet parking services. Leveraging its clinical expertise and strengths in research and development, the Group will also provide medical education and research through its College of Medicine at BMC, beginning in 2023. The Group is a leading healthcare provider in the UAE private market, with an in-patient market share of approximately 17 per cent. and an out-patient market share of approximately 12 per cent. and a total in-patient admission bed capacity of 1,294 beds as at 30 June 2022. The Group treated 105 thousand in-patients and 4.8 million out-patients in 2021 across its network, with comprehensive service offerings for oncology, women and child, orthopaedics and spine, cardiac science and bariatrics. BMC is also the only European Society for Medical Oncology-accredited cancer centre in the UAE and the largest private hospital in the UAE. The quality of the Group’s portfolio of medical facilities is evidenced by its operating 12 hospitals with JCI accreditations, three hospitals with ISOC 9001:2015 certifications and eight labs with ISO 15189:2012 certifications.

Latest Pressrelease Summaries from BURJEEL HOLDINGS PLC

Burjeel Holdings PLC has released its interim condensed consolidated financial statements for the nine-month period ending on September 30, 2024. These statements are unaudited.
Burjeel Holdings, a leading healthcare services provider in the MENA region, reported mid-teens revenue growth for the third quarter of 2024, with a 12% increase in patient footfall. The group's revenue reached AED 1.3 billion, supported by strong patient growth and improved patient yield. Despite ongoing investments in oncology, network expansion, and marketing, the group's net profit before taxes also improved. Hospital revenue rose to AED 1.2 billion, driven by a 34% year-over-year increase in the oncology segment, and hospital net profit before taxes increased significantly. Burjeel Holdings continued its strategic growth plan, focusing on expanding in the UAE and entering the Saudi Arabian market, along with enhancing its super-specialty care offerings. Key achievements included launching the UAE's largest fertility center and partnering with the Abu Dhabi Stem Cells Center to advance care for complex medical conditions.
Burjeel Holdings PLC has released its interim condensed consolidated financial statements for the nine-month period ending on September 30, 2024. These statements are unaudited.
Resolution No. 492 of 2024 involves the temporary suspension of trading for BURJEEL HOLDINGS PLC shares on the Abu Dhabi Securities Exchange (ADX). The suspension is due to a Board of Directors meeting scheduled for 14:00 on November 5, 2024, which coincides with the trading session. Trading will be halted from this time until the results of the meeting are received by ADX. The resolution requires all ADX department heads to implement it within their respective areas. Additionally, the resolution will be communicated to the Securities and Commodities Authority (SCA), the concerned company, all ADX departments, and accredited brokers. The resolution was approved by the authorized person and issued on October 30, 2024.
Burjeel Holdings PLC, a prominent healthcare provider in the MENA region, has announced the opening of nine new primary care clinics across Abu Dhabi, Al Ain, and Dubai. This expansion aims to improve access to comprehensive primary care services, supporting the UAE's healthcare strategy focused on preventive care and chronic condition management. The clinics will enhance Burjeel's hub-and-spoke network, expected to handle over 300,000 outpatient visits annually and facilitate cross-group referrals. The new facilities, resulting from a 20 million AED investment, are strategically located to serve diverse communities, including industrial workers and expatriates. Burjeel Holdings, founded in 2007, operates a wide network of healthcare services across the UAE, Oman, and Saudi Arabia.
Burjeel Holdings has expanded its PhysioTherabia network to 28 centers in Saudi Arabia by launching 11 new locations. This expansion makes PhysioTherabia the largest and fastest-growing physiotherapy and wellness network in the country, with centers in cities like Riyadh, Jeddah, Madina, and Dammam. The initiative aligns with Burjeel's strategy to open 60 centers by 2025 and supports Saudi Vision 2030's goals of enhancing healthcare access. PhysioTherabia offers various services, including sports injury rehabilitation and chronic pain management, and has partnered with major insurance providers to increase service accessibility. The expansion is part of a joint venture with Leejam Sports Company and aims to integrate sports and health to promote active lifestyles in Saudi Arabia.
Burjeel Holdings PLC, a healthcare provider in the MENA region, has signed a Memorandum of Understanding with Modon Holding to develop healthcare facilities in Ras El Hekma, Egypt. This collaboration aims to expand access to high-quality healthcare services in the area, which is set to become a significant economic and investment hub. The agreement includes developing multi-specialty healthcare facilities, implementing innovative healthcare solutions, and providing medical training programs to enhance local healthcare professionals' skills. The initiative also focuses on public health and wellness programs to improve community health outcomes. Ras El Hekma is a major development project with investments of USD 35 billion, featuring residential, commercial, and tourist facilities. The collaboration is part of efforts to build integrated services in Ras El Hekma, contributing to economic growth and improving the quality of life for residents and visitors. Burjeel Holdings, founded in 2007, operates a network of healthcare facilities across the UAE, Oman, and Saudi Arabia.
Axiom Space and Burjeel Holdings have signed a Memorandum of Understanding to conduct scientific research and test new technologies in space, focusing on how the human body reacts in microgravity. The collaboration aims to expand access to microgravity for medical advancements. The announcement was made at a signing ceremony in New York, attended by key executives from both organizations. As their first initiative, they plan to send a suite of medical capabilities to space, which will be used by Axiom Space astronauts during their training and the upcoming Axiom Mission 4 (Ax-4). This research will study the effects of microgravity on biomarkers, drug substance quality, and remote health services. The partnership is intended to benefit medical innovation and patient outcomes globally, aligning with the UAE's vision for space exploration.

Threads

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC General Press Release

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC General Press Release

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC Board Meeting Results held on 07/05/2024 at 17:00

The Board of Directors of Burjeel Holdings PLC virtually convened on 07/05/2024 at 5:00 PM UAE time. The board reviewed and approved the company's financial statements for the first quarter of the financial year 2024. They also discussed other business matters that have no effect on the share price. The meeting was led by the company's Chief Executive Officer, John Sunil. The Securities and Commodities Authority (SCA) was also copied on this correspondence.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC Press Release on the Financial Results for the Period Ended March 31,2024

Burjeel Holdings PLC, a leading healthcare services provider in the Middle East and North Africa (MENA) region, reported double-digit revenue growth for Q1 2024. The group's revenue grew by 11% to AED 1.2 billion, with a net profit of AED 141 million, an increase of 16%. This growth was attributed to increased operational efficiencies, lower finance costs, and the early start of Ramadan. The company also reported a 22% increase in BMC revenue to AED 283 million, driven by higher patient footfall and the expansion of super-specialty services. The company continues to invest in complex care and aims to expand its healthcare infrastructure.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC Management Discussion and Analysis Report for the Period Ended March 31,2024

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC Announcement of Board Meeting to be held on 07/05/2024 at 17:00

A letter was sent by John Sunil, the CEO of Burjeel Holdings PLC, to Dr. Maryam Buti Al Suwaidi, the CEO of the Securities and Commodities Authority in Abu Dhabi, UAE. The letter informed her of a virtual meeting of Burjeel Holdings PLC's Board of Directors scheduled for Tuesday, 7/5/2024 at 5:00PM UAE time. The agenda for the meeting included the review and potential approval of the company's financial statements for the first quarter of 2024, as well as the discussion of general business matters that do not impact the share price.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC AGM Minutes held on 05/04/2024 at 16:00

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC AGM Minutes held on 05/04/2024 at 16:00

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC General Press Release

Burjeel Holdings, a leading healthcare services provider in the MENA region, has announced a long-term ESG (Environmental, Social, and Governance) strategy. The strategy, which has been approved by the company's board of directors, is designed to position Burjeel as an ethical leader in the healthcare industry. The strategy is centered around four key pillars: Healthy Environment, Healthy Community, Healthy Governance, and Healthy System. These pillars aim to promote a clean environment, well-being in the community, transparent governance, and a safe, adaptable system. This move is part of Burjeel’s mission to provide high-quality healthcare to communities in the GCC and to promote a sustainable work environment for its employees.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC Invitation to Attend AGM held on 05/04/2024 at 15:30

Burjeel Holdings PLC has announced its annual general meeting (AGM) to be held on 5th April 2024 at 3:30pm (UAE Time) at the Burjeel Hospital in Abu Dhabi, UAE, and via video conferencing. The meeting will discuss several resolutions including the approval of the company's audited annual financial statements for the financial year ended 31 December 2023, the approval of an interim cash dividend, and the approval of the Board of Director's fees and performance bonus. Other items on the agenda include absolving the Board of Directors and auditors from liability for the financial year ended 31 December 2023, and the appointment of external auditors for the financial year ending 31 December 2024. The meeting will also consider the amendment of Article 3 of the Company’s Articles of Association. Shareholders are encouraged to attend, either in person or via proxy.

1. Attached Document